SGLT2 inhibitor (not specified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SGLT2 inhibitor (not specified), covering 2023-01-17 to 2023-01-17. Get the full timeline:
Most recent: Clinical Trial Update: Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition [Phase 1]